Inpharma

Transdermal rivastigmine more IDEAL than oral in Alzheimer's disease?
pp. 1-1(1)

Is the use of placebos justified in advanced cancer trials?
pp. 2-2(1)

Legislation promotes development of paediatric drugs
pp. 3-3(1)

`Polypill' has potential to prevent diabetic complications
pp. 3-3(1)

The Group of Eight (G8) has expressed commitment to improve surveillance for infectious diseases and to improve transparency by all countries
pp. 3-3(1)

Mylan Laboratories has testified before the US Senate Special Committee on Aging on the tactics used by brand pharmaceutical companies
pp. 3-3(1)

Results from a survey conducted by the Union of Concerned Scientists (UCS) show that US FDA scientists are under pressure
pp. 3-3(1)

Lamotrigine and lithium best bets in bipolar I disorders
pp. 4-4(1)

Rimonabant reduces BMI at a cost
pp. 4-4(1)

Report recommends safety changes for phase I trials
pp. 4-4(1)

Tadalafil tops in erectile dysfunction
pp. 5-5(1)

Lamivudine monotherapy best bet in preventing HBV recurrence
pp. 5-5(1)

Ropinirole lacks dominance in restless legs syndrome
pp. 6-6(1)

The combined osteoporosis treatment alendronic acid/colecalciferol [Fosavance] is cost saving and more effective than ibandronic acid
pp. 6-6(1)

MPC 7869 has long-term efficacy in Alzheimer's disease
pp. 6-6(1)

Oral RSD 1235 appears to prevent recurrence of atrial fibrillation
pp. 6-6(1)

Roflumilast a real contender for COPD
pp. 7-8(2)

The BLP25 cancer vaccine [Stimuvax] slows rising prostate specific antigen (PSA) levels in post-surgical prostate cancer patients
pp. 8-8(1)

Pioglitazone may prolong memory and brain function in patients with Alzheimer's disease
pp. 8-8(1)

Clindamycin cream for BV prolongs pregnancy, reduces costs
pp. 9-9(1)

Toremifene reduces premenstrual breast pain
pp. 9-9(1)

PBT 2 improves memory performance as well as beta-amyloid levels in murine models of Alzheimer's disease
pp. 9-9(1)

Certolizumab pegol, a humanised, pegylated anti-TNF-α antibody fragment, is effective for moderate-to-severe chronic plaque psoriasis
pp. 9-9(1)

VGV 1 leads to sustained reductions in viral load in patients with HIV infection
pp. 9-9(1)

Metoclopramide prevents postoperative nausea and vomiting
pp. 10-10(1)

Early prophylaxis with meropenem in necrotising acute pancreatitis reduces the incidence of septic complications
pp. 10-10(1)

Rosuvastatin superior for hypercholesterolaemia
pp. 10-10(1)

Antibacterial lock therapy (ALT) plus systemic antibacterials may be effective for the treatment of catheter-related bacteraemia
pp. 10-10(1)

Cyanocobalamin [vitamin B12] plus folic acid lowers homocysteine levels in patients with Parkinson's disease
pp. 10-10(1)

Venlafaxine XR PREVENTs the recurrence of depression
pp. 11-12(2)

Furosemide ineffectual for acute renal failure
pp. 13-13(1)

Gabapentin shows efficacy comparable to estrogen for the treatment of hot flushes in postmenopausal women
pp. 13-13(1)

Tolterodine ER makes an IMPACT in overactive bladder
pp. 13-13(1)

Lanthanum carbonate effectively reduces phosphate levels in previously treated patients on dialysis
pp. 13-13(1)

A betamethasone foam preparation is as effective as a cream for plaque psoriasis, with greater patient-rated usability
pp. 13-13(1)

Efavirenz tops nelfinavir or combination for initial ART
pp. 14-14(1)

Valaciclovir limits recurrence of genital HSV in late pregnancy
pp. 14-14(1)

Methyl aminolevulinate photochemotherapy in SCC
pp. 14-14(1)

A combination of mycophenolate mofetil, low-dose tacrolimus, corticosteroids and interleukin-2 is best for renal transplant recipients
pp. 14-14(1)

Alemtuzumab: an effective front-line option for CLL?
pp. 15-16(2)

Formoterol/budesonide good, salmeterol/fluticasone EXCEL-lent
pp. 16-16(1)

Statins, ARBs, ACE inhibitors protective in patients with COPD
pp. 17-17(1)

A single, topical iontophoretic application of aciclovir improves the healing time of herpes labialis lesions
pp. 17-17(1)

Antipsychotic response attenuates after 4 weeks
pp. 17-17(1)

Adding cytokine-induced killer (CIK) cell therapy to the FOLFOX4 regimen is beneficial for treating advanced gastric cancer
pp. 18-18(1)

Combining bortezomib with dexamethasone improves outcomes in patients with relapsed and/or refractory multiple myeloma (MM) not responding to bortezomib monotherapy
pp. 18-18(1)

Mediterranean-style diets beneficial for cardiovascular risk factors
pp. 18-18(1)

Albendazole, praziquantel beneficial for neurocysticercosis
pp. 18-18(1)

Ciclosporin has equivalent efficacy to tacrolimus and is associated with a lower incidence of new-onset diabetes
pp. 18-18(1)

Should antibacterials be used for acute purulent rhinitis?
pp. 19-19(1)

The cardioprotective benefits of soy isoflavones may be related to their effects on platelet function
pp. 19-19(1)

Inhaled levosalbutamol [levalbuterol] is an effective treatment for children with asthma
pp. 19-19(1)

The pharmacokinetics (PK) of primaquine are affected by grapefruit juice and food, but not gender
pp. 19-19(1)

Eradication of Helicobacter pylori infection increases absorption of levodopa and improves clinical symptoms in patients with Parkinson's disease
pp. 19-19(1)

NRTIs associated with hepatic steatosis in HIV/HCV co-infection
pp. 20-20(1)

Elderly at risk of severe cataracts with inhaled corticosteroids
pp. 20-20(1)

Norgestimate and levonorgestrel: similar VTE risk
pp. 20-20(1)

The US FDA is warning consumers and healthcare providers against using bismacine, also known as chromacine.
pp. 20-20(1)

Genetic polymorphism behind rosiglitazone-related weight gain
pp. 21-21(1)

EU product approvals
pp. 21-21(1)

Other US regulatory news
pp. 21-21(1)

A warning on the dangers of excess paracetamol [acetaminophen] has been issued by the American Liver Foundation
pp. 21-21(1)

The antimalarial combination of artemisinin plus naphthoquine [Arco] has been launched in Nigeria
pp. 22-22(1)

US product approvals
pp. 22-22(1)

Other EU regulatory news
pp. 22-22(1)

European product launches
pp. 22-22(1)

India's Drug Controller General has granted marketing approval to YM BioSciences' nimotuzumab
pp. 22-22(1)

The Australian Therapeutic Goods Administration has approved AstraZeneca's budesonide/formoterol maintenance and reliever therapy
pp. 22-22(1)

US product launches
pp. 23-23(1)

Health Canada has approved Merck Frosst's recombinant quadrivalent human papillomavirus vaccine [Gardasil]
pp. 23-23(1)

The recombinant quadrivalent human papillomavirus vaccine [Gardasil] has been approved in New Zealand
pp. 23-23(1)